Dr. Rothenberg is an internationally recognized oncologist with more than 30 years of experience in medical oncology, academic research, and biopharmaceutical industry leadership. He has published more than 100 articles and book chapters, primarily in the areas of early-stage drug development, gastrointestinal malignancies and ovarian cancer. Not only that, but within his time as a Chief Medical Officer in Pfizer, the company has initiated, completed and obtained the emergency use authorization for the COVID-19 Vaccine. Also, while Dr. Rothenberg was the Head of Clinical Development and Medical Affairs for Pfizer’s Oncology Business Unit, his organization developed and obtained regulatory approval for 11 new cancer medicines.

Dr. Rothenberg will be joining us in our seventh Pioneers in Medicine webinar on May 7, at 12:00 PM. He will be discussing his personal experience in the medical field, how he reached his achievements and the obstacles he faced. This event will be streamed live on IJCR’s website